UK CMOs to advise on COVID-19 jabs for 12- 15-year-olds

The government has asked the UK's four chief medical officers (CMOs) to advise on possible rollout of COVID-19 jabs for people aged 12 to 15 after the JCVI said health benefits 'marginally outweigh' potential risk in this group.

COVID-19 vaccine (Photo: Catherine Falls Commercial/Getty Images)

The Pfizer/BioNTech and Moderna vaccines have been approved by the MHRA for use in patients aged 12 and over.

Experts on the Joint Committee on Vaccination and Immunisation (JCVI) have now advised the government that the health benefits of vaccination in people aged 12-15 are marginally higher than the potential risks - but advised ministers to seek further input from the CMOs.

The UK's four CMOs will consider factors such as the impact on schools and young people’s education in addition to the direct health benefits of vaccination in this group.

COVID-19 vaccination

Health ministers across the four UK nations have written to the CMOs, who are now expected to consult experts and senior clinical and public health leaders over the way forward.

People aged 12 to 15 who are clinically vulnerable to COVID-19 or who live with adults who are at increased risk of serious illness from the virus are already eligible for a COVID-19 vaccine and are being contacted by the NHS, to be invited to come forward.

The JCVI has advised that this offer should be expanded to include more children aged 12 to 15, for example those with sickle cell disease or type 1 diabetes.

Health and social care secretary Sajid Javid said: 'Our COVID-19 vaccines have brought a wide range of benefits to the country, from saving lives and preventing hospitalisations, to helping stop infections and allowing children to return to school.

JCVI advice

'I am grateful for the expert advice that I have received from the independent Joint Committee on Vaccination and Immunisation.

'People aged 12 to 15 who are clinically vulnerable to the virus have already been offered a COVID-19 vaccine, and today we’ll be expanding the offer to those with conditions such as sickle cell disease or type 1 diabetes to protect even more vulnerable children.

'Along with Health Ministers across the four nations, I have today written to the CMOs to ask that they consider the vaccination of 12 to 15 year olds from a broader perspective, as suggested by the JCVI.

'We will then consider the advice from the Chief Medical Officers, building on the advice from the JCVI, before making a decision shortly.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Just published

Closed sign

GP contract changes 'could lead to more practice closures'

Changes to the GP contract for 2023/24 could lead to more practice closures and more...

Talking General Practice

Podcast: Will GPs take industrial action, patientsā€™ views on the NHS, junior doctor dispute

The team looks at whether GPs will be prepared to take industrial action and the...

GP at desk

GPs to 'exception report' appointments booked over two weeks ahead

GP practices will be able to 'exception report' appointments booked deliberately...

GP sign

Contract update hands practices just six weeks to agree access improvement plans

GP practices have just six weeks to agree access improvement plans covering patient...

GP appointment

GP anger over last-minute release of contract detail for 2023/24

GP leaders have hit out at NHS England after it waited until just two days before...

GP consulting room

GP appointments surge 10% above pre-pandemic level

GP practices in England delivered 10% more appointments in February this year compared...